Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

19%

6 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (9)
P 1 (1)
P 2 (2)
P 4 (6)

Trial Status

Unknown14
Completed9
Recruiting6
Not Yet Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT06590454Phase 2RecruitingPrimary

REVerse Intestinal Metaplasia in the Stomach (REVISE)

NCT06370143Recruiting

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

NCT06610760Phase 4RecruitingPrimary

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia

NCT07208864Not ApplicableNot Yet RecruitingPrimary

Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score

NCT07129460Phase 4Not Yet RecruitingPrimary

Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia

NCT06610266Phase 4RecruitingPrimary

Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

NCT02794428Phase 2Completed

Chemoprevention of Gastric Carcinogenesis

NCT05288153Phase 4CompletedPrimary

Metformin Efficacy and Safety for Gastric Intestinal Metaplasia

NCT05657080Recruiting

Cytosponge for Gastric Intestinal Metaplasia

NCT05447221UnknownPrimary

Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis System

NCT04348266Not ApplicableCompletedPrimary

RFA for GIM Treatment

NCT05345314Completed

Endoscopic Grading of Intestinal Metaplasia

NCT04869618Not ApplicableUnknown

Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer

NCT04843397Unknown

Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study

NCT04365946UnknownPrimary

Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes Correlation

NCT03672708Not ApplicableCompletedPrimary

Confocal Laser Endomicroscopy With Cresyl Violet for in Vivo Diagnosis of Gastric Intestinal Metaplasia

NCT03250091Recruiting

Surveillance of Patients With Precancerous Lesions of the Stomach

NCT02930616Phase 4UnknownPrimary

A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized,Cross-over Study

NCT02846688Completed

Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa

NCT02806115Phase 1UnknownPrimary

The Efficacy of Severe Whitening and Delayed Fading in Acetic Acid-enhanced Endoscopy for Diagnosing Gastric Intestinal Metaplasia

Scroll to load more

Research Network

Activity Timeline